The full report is titled “Association Between Efavirenz as Initial Therapy for HIV-1 Infection and Increased Risk for Suicidal Ideation or Attempted or Completed Suicide. An Analysis of Trial Data.” It is in the 1 July 2014 issue of Annals of Internal Medicine (volume 161, pages 1-10). The authors are K.R. Mollan, M. Smurzynski, J.J. Eron, E.S. Daar, T.B. Campbell, P.E. Sax, R.M. Gulick, L. Na, L. O’Keefe, K.R. Robertson, and C. Tierney.
Efavirenz and the Risk for Suicidal Behaviors. Ann Intern Med. 2014;161:I–14. doi: https://doi.org/10.7326/P14-9019
Download citation file:
Published: Ann Intern Med. 2014;161(1):I-14.
HIV, Infectious Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use